Skip to main content
. 2015 Oct 5;2015:927123. doi: 10.1155/2015/927123

Figure 2.

Figure 2

EFS for 1444 patients enrolled in consecutive COG trials. The 5-year EFS for the group was 68.32%  ± 1.3%. EFS = event-free survival; COG = Children's Oncology Group.